Last $3.31 USD
Change Today +0.01 / 0.30%
Volume 60.8K
OGXI On Other Exchanges
Symbol
Exchange
Munich
NASDAQ CM
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - oncogenex pharmaceutical inc (OGXI)

NameBoard RelationshipsTitleAge
Scott Daniel Cormack 13 RelationshipsFounder, Chief Executive Officer, President, Treasurer, Secretary and Director49
John A. Bencich M.B.A.No RelationshipsChief Financial Officer and Vice President37
Cindy Jacobs Ph.D., M.D.No RelationshipsChief Medical Officer and Executive Vice President56
Jaime Welch No RelationshipsVice President of Marketing & Corporate Communications--
Monica Krieger Ph.D.No RelationshipsVice President of Regulatory Affairs65

Board Members - oncogenex pharmaceutical inc (OGXI)

NameBoard RelationshipsPrimary CompanyAge
Jack Goldstein Ph.D.12 RelationshipsOncoGenex Pharmaceuticals, Inc.66
Scott Daniel Cormack 13 RelationshipsOncoGenex Pharmaceuticals, Inc.49
Neil James Clendeninn M.D., Ph.D.5 RelationshipsCato BioVentures64
H. Stewart Parker 148 RelationshipsInfectious Disease Research Institute58
David V. Smith 5 RelationshipsIntegenX Inc.54

Executive Committees* - oncogenex pharmaceutical inc (OGXI)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeDavid V. Smith 5 Relationships4 Executives
Compensation CommitteeNeil James Clendeninn M.D., Ph.D. 5 Relationships3 Executives
Nominating CommitteeH. Stewart Parker 148 Relationships4 Executives
Corporate Governance CommitteeH. Stewart Parker 148 Relationships4 Executives
View OGXI Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $3.31 USD +0.01

OGXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OGXI.
View Industry Companies
 

Industry Analysis

OGXI

Industry Average

Valuation OGXI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.